ARCHIVES

DCT Board Approves Contract Recompetitions Worth 44.8 Million In First Year Awards

This article is from The Cancer Letter archive.

Vol. 08 No. 43 | November 5, 1982

Download PDF Visit The Full Archive

Related Articles

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

March 10, 1989

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012

President Obama Signs Spending Bill Giving NCI 2.8 Percent Increase

December 18, 2009

Rauscher Tells Flood Subcommittee How He Would Spend An Extra $50 Million-On Centers, Grants

April 12, 1974

Biomedical Panel To Hear Public At Sept. Meeting

July 11, 1975

NCI Bypass Budget Seeks $3.64 Billion

January 20, 1995